Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
11/2000
11/15/2000EP1051433A2 Antimicrobial peptides
11/15/2000EP1051354A2 Water purification apparatus with a hydrophilic membrane
11/15/2000EP1051217A1 Osmotic drug delivery monitoring system and method
11/15/2000EP1051194A1 Process for making absorbable microparticles
11/15/2000EP1051193A1 Anhydrous topical skin preparations
11/15/2000EP1051190A1 Vaccine compositions for mucosal administration comprising chitosan
11/15/2000EP1051189A2 Vaccine formulations
11/15/2000EP1051188A1 Mucosal delivery system comprising lipophilic thrombin inhibitors
11/15/2000EP1051186A2 Synergistic mixtures of garlic and lycopene for preventing ldl oxidation
11/15/2000EP1051182A1 Methods of decreasing or preventing pain using spicamycin or derivatives thereof
11/15/2000EP1051181A2 Water soluble prodrugs of secondary and tertiary amine containing drugs and methods of making thereof
11/15/2000EP1051174A1 Gastroprotected omerprazole microgranules, method for obtaining same and pharmaceutical preparations
11/15/2000EP1051167A1 Pharmaceutical uses of optically pure (-) -bupropion
11/15/2000EP1051166A1 Pharmaceutical uses of optically pure (+) -bupropion
11/15/2000EP1051164A1 Pharmacological uses of pure (+) -bupropion
11/15/2000EP1051163A2 Methods and compositions for aiding in smoking cessation and for treating pain and other disorders using optically pure (-)-bupropion
11/15/2000EP1051162A1 Methods and kits for treating vulvovaginal candidiasis with miconazole nitrate
11/15/2000EP1051160A1 Pharmaceutical compositions in form of nanoparticles comprising lipidic substances and amphiphilic substances and related preparation process
11/15/2000EP1051159A1 Solid pharmaceutical compositions containing miltefosine for oral administration in the treatment of leishmaniasis
11/15/2000EP1051158A2 Pharmaceutical compositions in form of polymeric microparticles obtained by extrusion and spheronization
11/15/2000EP1051157A2 Controlled release delivery of peptide or protein
11/15/2000EP1051156A2 Pharmaceutical compositions
11/15/2000EP1051155A1 Nasal solutions
11/15/2000EP1051154A1 Microparticle inhalation formulations
11/15/2000EP0721325B1 Method of applying an indicia to a fast-dissolving dosage form
11/15/2000EP0686045B1 Excipient stabilization of polypeptides treated with organic solvents
11/15/2000CN2405592Y Leakage-proof protective pad for plaster
11/15/2000CN2405591Y Pressure-sensitive skin plaster capable of diminishing wrinkle of skin
11/15/2000CN2405590Y Magnetic medicated plaster
11/15/2000CN1273530A Method to potentiate intraveneous estramustin phosphate
11/15/2000CN1273527A Taste masked pharmaceutical compositions
11/15/2000CN1273526A Microdisperse drug delivery systems
11/15/2000CN1273199A Sealing machine for hard capsules
11/15/2000CN1273117A Process for preparing plaster for treating rheumatism
11/15/2000CN1273116A Process for refining astragalus injection
11/15/2000CN1273115A Process for refining injection 'Shuanghuanglian'
11/15/2000CN1273114A Process for refining injection 'Xuesaitong'
11/15/2000CN1273107A Xinnaofukang capsule-for treating angiocardiopathy and cerebrovascular disease and its preparing process
11/15/2000CN1273103A Chinese-medicinal pill for treating hepatism
11/15/2000CN1273100A Anticancer detoxicating pill and its preparing process
11/15/2000CN1273092A Water-soluble powdered quinolone medicines
11/15/2000CN1273091A Slowly releasing piperazine ferulate
11/15/2000CN1273090A Plastic for treating mastoplasia and method for preparing it
11/15/2000CN1273089A Plaster with magnetic field effect
11/15/2000CN1058411C High-grade lift-prolonging health oral liquid
11/15/2000CN1058408C Nasitis powder and producing process thereof
11/15/2000CN1058402C Zhongfengkang instant powder for curing appoplexy
11/15/2000CN1058398C Chinese medicine for treatment of gynecopathy and preparation method thereof
11/15/2000CN1058397C Wound sticker and its preparing method
11/15/2000CN1058395C Inhalant for prevention and treatment of baldness
11/15/2000CN1058391C Prepared anthracene ring glucosides anticancer solution for injection
11/15/2000CN1058388C Stable freeze dried polyhematoporphyrin ether/ester composition
11/15/2000CN1058387C Use of asymmetric membranes in delivery devices
11/15/2000CN1058381C Method for preparing stable water composition composition made by the method and product containing the composition
11/14/2000US6147204 Complex for targeting therapeutic or diagnostic agents to preferential biological target
11/14/2000US6147168 Copolymers of absorbable polyoxaesters
11/14/2000US6147135 Fabrication of biocompatible polymeric composites
11/14/2000US6147122 Oil in water emulsion used for injection with antimicrobial growth agent; prevents growth of escherchia, candida, pseudomonas, and staphylococcus
11/14/2000US6147102 Topical aqueous gel suitable for relieving sympathetically maintained peripheral neuropathic pain syndrome
11/14/2000US6147077 2R,4S-hydroxyitraconazole isomers
11/14/2000US6147064 Oral 1α-hydroxyprevitamin D in composition and method for treating psoriasis
11/14/2000US6147059 Accumulation a drug in skin
11/14/2000US6147056 Therapy for psoriasis
11/14/2000US6147053 Combination containing growth factors and polyelectrolytes
11/14/2000US6146825 Encapsulation of oleophilic substances and compositions produced thereby
11/14/2000US6146685 Particles deposited form a low density, high relative void deposition to minimize attractive forces between particles, minimizing agglomeration and bonding forces to the substrate, facilitating the release of powdered medicament in an inhaler
11/14/2000US6146665 In an aqueous solution of hydrophilic drug, synthesizing a polyhydroxyalkanoate by in vitro enzyme polymerization of a coenzyme a-hydroxyalkanoic acid precursor monomer to form microporous granules entrapping the dissolved drug
11/14/2000US6146664 Stable topical ascorbic acid compositions
11/14/2000US6146663 Comprising hydrophobic, water-insoluble (co)polymer suspended in an aqueous solution or dispersion of a phospholipid and a bile salt; polymer cannot be dispersed in water without the aid of a dispersing agent; nonagglomerating
11/14/2000US6146662 Dosage form of calcium channel blocker drug, and a polymer of given molecular weight and rate of hydration that changes the form from non-dispensable phase to a dispensable phase; and a drug-delayed delivery composition comprising a polymer
11/14/2000US6146661 Which contains erythritol and optionally another sugar alcohol, with a dissolution endotherm of 20 cal or more per gram of gastrointestinal drug, and gastrointestinal drug such as sucralfate; oral administration without water or bad taste
11/14/2000US6146659 Method of administering liposomal encapsulated taxane
11/14/2000US6146658 Prodrugs, their preparation and use as pharmaceuticals
11/14/2000US6146657 Liposome filled with an insoluble gas and a soluble gas, wherein said liposome comprises phosphatidylcholine(s), phosphatidylethanolamine(s), and phosphatidic acid(s); use in ultrasonic or magnetic resonance imaging
11/14/2000US6146656 Comprising a skin contact base containing biperiden-hcl and a freeing agent, the skin contact base is pressure sensitive adhesive layer having adhesion at room temperature on one side of a backing material; for treating parkinson's disease
11/14/2000US6146655 Kit of hydrolyzable powder/water-wettable fiber mixture enclosed in a flexible, water permeable non-stick envelope; the envelope is immersed in water or medication to wet the hydrolyzable powder/fiber mixture to form tacky moldable gel
11/14/2000US6146654 Water-soluble hydrophilic composition and a medicament, dispersed into a binder capable of retaining the medicament-containing hydrophilic composition; amount of drug released controlled according to degree of moisture present at site
11/14/2000US6146649 Photobluing/whitening-resistant cosmetic/dermatological compositions comprising TiO2 pigments and deformable hollow particulates
11/14/2000US6146645 Uses of oil bodies
11/14/2000US6146639 Arthritis, muscle pain, and dry skin remedy
11/14/2000US6146632 Vaccines
11/14/2000US6146622 Use of certain anionic amino acid based surfactants to enhance antimicrobial effectiveness of topically administrable pharmaceutical compositions
11/14/2000CA2179207C Parathyroid hormone formulation
11/14/2000CA2000763C Dispersable formulation
11/10/2000CA2307958A1 Patch and method for transdermal delivery of bupropion base
11/09/2000WO2000066688A1 Cleaning compositions and tablets
11/09/2000WO2000066665A1 Stable, aqueous dispersions and stable, water-dispersible dry powders of xanthophylls, and production and use of the same
11/09/2000WO2000066635A1 Amphiphile cyclodextrins, preparation and use thereof for solubilising organised systems and incorporating hydrophobic molecules
11/09/2000WO2000066572A1 Substituted bicyclic heterocycles, process for their preparation and their use as antiobesity and hypocholesterolemic agents
11/09/2000WO2000066371A1 Device for applying an adhesive skin tattoo and for administering a pharmaceutical and/or cosmetic product
11/09/2000WO2000066256A1 Spray drying apparatus and methods of use
11/09/2000WO2000066206A2 Compositions for aerosolization and inhalation
11/09/2000WO2000066204A1 Implantable microbolus infusion pump
11/09/2000WO2000066183A1 Vascular embolic materials having multifunctions
11/09/2000WO2000066182A1 X-ray guided drug delivery
11/09/2000WO2000066179A1 Noninvasive genetic immunization, expression products therefrom, and uses thereof
11/09/2000WO2000066173A2 Targeting of infectious agents bearing host cell proteins
11/09/2000WO2000066172A1 Non-aqueous liquid shampoo composition
11/09/2000WO2000066171A1 Sugar alcohol granule aggregate and method for preparing the same
11/09/2000WO2000066170A1 Prucalopride oral solution
1 ... 2438 2439 2440 2441 2442 2443 2444 2445 2446 2447 2448 2449 2450 2451 2452 2453 2454 2455 2456 2457 2458 ... 2991